Reduced insulin resistance decreases ChREBP-mediated de novo lipogenesis by promoting glucose utilization in the liver, and by inhibiting hepatic gluconeogenesis, decreasing the accumulation of lipids [26, 27]. Here, MLXIPL is linked to Insulin resistance.